Biocompatibility of adenoviral vectors in poly(vinyl chloride) tubing catheters with presence or absence of plasticizer di-2-ethylhexyl phthalate.
Adenoviral (Ad) vectors feature attractive characteristics for gene therapy of a wide variety of diseases. In many cases, the Ad vector must be administered using catheters and other plastic medical devices. Although poly(vinyl chloride) is one of the most frequently used catheter materials, it is relatively rigid and requires the addition of a plasticizer such as di-2-ethylhexyl phthalate (DEHP) to increase its flexibility. In this study, we demonstrated that exposure to a DEHP-containing catheter decreased the infectivity of Ad vectors but not the total particle number of the vector. Loss of Ad vector infectivity was directly related to the time of exposure to the DEHP-containing catheter, but it was not due to simple leaching of the chemical from the plastic. The loss of Ad vector infectivity could be prevented by preflushing the tube with albumin. Careful consideration of the compatibility between gene therapy vectors and medical delivery devices will be critical to the success of human gene therapy applications.
Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.
Roberto
R
Bilbao
Daniel P
DP
Reay
Bhanu M
BM
Koppanati
Paula R
PR
Clemens
D000256:Adenoviridae; D001672:Biocompatible Materials; D002404:Catheterization; D002460:Cell Line; D004051:Diethylhexyl Phthalate; D015316:Genetic Therapy / Q000295:instrumentation* / Q000379:methods; D005822:Genetic Vectors / Q000737:chemistry; D006801:Humans; D008422:Materials Testing; D011143:Polyvinyl Chloride; D012709:Serum Albumin
D001672:Biocompatible Materials; D012709:Serum Albumin; D011143:Polyvinyl Chloride; D004051:Diethylhexyl Phthalate